Steadfast Medishield Pvt. Ltd. (D) || View more products from Steadfast Medishield Pvt. Ltd. (D)
About Aplazar Tablet :
Each film-coated Aplazar tablet contains Calcium-3-methyl-2-oxo-valerate 67 mg (Alpha-ketoanalogue to isoleucine, Calcium salt), Calcium-4-methyl-2-oxo-valerate 101 mg (Alpha-ketoanalogue to leucine, Calcium salt), Calcium-2-oxo-3-phenylpropionate 68 mg (Alpha-ketoanalogue to phenylalanine, Calcium salt), Calcium-3-methyl-2-oxo-butyrate 86 mg (Alpha-ketoanalogue to valine, Calcium salt), Calcium-DL-2-hydroxy-4-(methylthio) butyrate 59 mg (Alpha-hydroxyanalogue to methionine, Calcium Salt), L-Lysine Acetate 105 mg (equivalent to L-Lysine 75 mg), L-Threonine 53 mg, L-Tryptophan 23 mg, L-Histidine 38 mg, L-Tyrosine 30 mg, Total nitrogen content per tablet 36 mg, Calcium content per tablet 1.25 mmol=0.05 g and Excipients q.s.
Use of Aplazar Tablet :
Aplazar tablet is used to prescribe for the treatment of chronic kidney Disease patients on Conservative management therapy (Stage I, II, III).
Usage direction of Aplazar Tablet:
Precaution & Related information of Aplazar Tablet :
MRP Rs. 390.00 | Discount 6%
10 Tablets
Best Before Mar 2026